Member Info for Chelsea11

And 2x 5 (or 6) given WTP posted the exact same link just a few hours back 🙄

Takeover target at this level.

Super post Ruck. Scancell relevant and all supporting context & opinion added (whether you agree with it, or not).

Noble Guardian.

I keep saying the same thing Moon. Posting crap just because it has Scancell’s name on it doesn’t help anyone, particularly when no context or explanation is offered by the poster.

It is explained in the Interim Results and relates to the Convertible Loan Notes.

Really though you could consider it accounting hocus-pocus and the Morning Star article is crap and should be ignored. They have made no effort to explain it and doubt the writer even understood what they were typing. Pointless and misleading article.

Cash runway to the second half of 2026 beyond multiple clinical milestones is all anyone needs to know about the financials, unless you are a corporate accountant and get off on that stuff.

Https://www.proactiveinvestors.co.uk/companies/news/1065398/scancell-holdings-interims-highlight-continued-progress-says-broker-1065398.html

Https://www.trinitydelta.org/research-notes/h125-reaffirms-funds-are-sufficient-to-deliver-key-data/

Nigh!

The end is night, apocalyptic posters seem to have disappeared up their own you know what around midday.

Probably time for your medication.

“We have the team and resources to execute the plan and we will do that”

Very confidently said.

Https://www.proactiveinvestors.com/companies/news/1065361/scancell-ceo-on-first-half-progress-and-2025-milestones-1065361.html

We’ve also learnt from this update, the up front cash in the bank to date from the 2nd Genmab collaboration ie. £3.9M

I’m hoping there are more buy trades than posts made here tomorrow!

Best of luck everyone.

Bland commentary on known SP movement.

Captain Obvious.

Probably not wise to encourage Ruck to get his tits out again.

Well I guess the original question can now be refined perhaps, to what is considered “sufficient data” from Cohorts 3 & 4.

Thanks for viewpoint Berm.

Thanks Chester. That’s helpful.

Thanks for all inputs although I remain confused. I guess the principal point I’m looking to understand is what are the minimum requirements needed to kick off the Registration Trial, from a data analysis perspective. Maybe I’m asking for an answer that as of now, cannot be provided.